Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
Publication
, Journal Article
Selvaraj, S; Kosiborod, MN; Shah, SH
Published in: Circulation
March 14, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
March 14, 2023
Volume
147
Issue
11
Start / End Page
922 / 923
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Glucosides
- Cardiovascular System & Hematology
- Benzhydryl Compounds
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Selvaraj, S., Kosiborod, M. N., & Shah, S. H. (2023). Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation, 147(11), 922–923. https://doi.org/10.1161/CIRCULATIONAHA.122.063395
Selvaraj, Senthil, Mikhail N. Kosiborod, and Svati H. Shah. “Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".” Circulation 147, no. 11 (March 14, 2023): 922–23. https://doi.org/10.1161/CIRCULATIONAHA.122.063395.
Selvaraj S, Kosiborod MN, Shah SH. Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation. 2023 Mar 14;147(11):922–3.
Selvaraj, Senthil, et al. “Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".” Circulation, vol. 147, no. 11, Mar. 2023, pp. 922–23. Pubmed, doi:10.1161/CIRCULATIONAHA.122.063395.
Selvaraj S, Kosiborod MN, Shah SH. Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation. 2023 Mar 14;147(11):922–923.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
March 14, 2023
Volume
147
Issue
11
Start / End Page
922 / 923
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Glucosides
- Cardiovascular System & Hematology
- Benzhydryl Compounds
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences